Table of Content

1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study


2 RESEARCH METHODOLOGY


3 EXECUTIVE SUMMARY


4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Incidence of Target Diseases and Geriatric Population
4.2.2 Growing Investments, Funds, and Grants
4.3 Market Restraints
4.3.1 Lack of Skilled and Experienced Electrophysiologists
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry


5 MARKET SEGMENTATION (Market Size by Value – USD million)
5.1 By Type
5.1.1 Contact Cardiac Mapping Systems
5.1.2 Non-Contact Cardiac Mapping Systems
5.2 Indication
5.2.1 Atrial Fibrillation
5.2.2 Atrial Flutter
5.2.3 Others
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle-East
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle-East
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America


6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Abbott Laboratories
6.1.2 Acutus Medical
6.1.3 Angiodynamics
6.1.4 APN Health, LLC
6.1.5 Biosense Webster, Inc.
6.1.6 Biosig Technologies, Inc.
6.1.7 Boston Scientific Corporation
6.1.8 Kardium, Inc.
6.1.9 Koninklijke Philips N.V.
6.1.10 Lepu Medical
6.1.11 Medtronic Plc
6.1.12 Microport Scientific Corporation


7 MARKET OPPORTUNITIES AND FUTURE TRENDS